82 related articles for article (PubMed ID: 23598882)
1. [Roles of phosphatidylethanolamine-binding protein in cell signaling and its biological functions].
Bian JM; Wu N; Li J
Sheng Li Xue Bao; 2013 Apr; 65(2):237-43. PubMed ID: 23598882
[TBL] [Abstract][Full Text] [Related]
2. [Phosphatidylethanolamine-binding protein (PEBP) in basic and clinical study].
Li FF; Song SJ; Zhang RN
Sheng Li Ke Xue Jin Zhan; 2009 Jul; 40(3):214-8. PubMed ID: 19803424
[TBL] [Abstract][Full Text] [Related]
3. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target.
Zeng L; Imamoto A; Rosner MR
Expert Opin Ther Targets; 2008 Oct; 12(10):1275-87. PubMed ID: 18781826
[TBL] [Abstract][Full Text] [Related]
4. Raf kinase inhibitor protein mediated signaling inhibits invasion and metastasis of hepatocellular carcinoma.
Wu X; Yang Y; Xu Z; Li J; Yang B; Feng N; Zhang Y; Wang S
Biochim Biophys Acta; 2016 Feb; 1860(2):384-91. PubMed ID: 26116914
[TBL] [Abstract][Full Text] [Related]
5. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein.
Keller ET; Fu Z; Brennan M
J Cell Biochem; 2005 Feb; 94(2):273-8. PubMed ID: 15565643
[TBL] [Abstract][Full Text] [Related]
6. Raf kinase inhibitor protein regulation of raf and MAPK signaling.
Hagan S; Garcia R; Dhillon A; Kolch W
Methods Enzymol; 2006; 407():248-59. PubMed ID: 16757329
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylethanolamine-binding protein is not involved in µ-opioid receptor-mediated regulation of extracellular signal-regulated kinase.
Bian JM; Wu N; Su RB; Li J
Mol Med Rep; 2015 May; 11(5):3368-74. PubMed ID: 25573435
[TBL] [Abstract][Full Text] [Related]
8. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor.
Granovsky AE; Rosner MR
Cell Res; 2008 Apr; 18(4):452-7. PubMed ID: 18379591
[TBL] [Abstract][Full Text] [Related]
9. The role of Raf kinase inhibitor protein (RKIP) in health and disease.
Keller ET; Fu Z; Brennan M
Biochem Pharmacol; 2004 Sep; 68(6):1049-53. PubMed ID: 15313400
[TBL] [Abstract][Full Text] [Related]
10. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
Lee S; Wottrich S; Bonavida B
Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
[TBL] [Abstract][Full Text] [Related]
11. Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease.
George AJ; Holsinger RM; McLean CA; Tan SS; Scott HS; Cardamone T; Cappai R; Masters CL; Li QX
Neurobiol Aging; 2006 Apr; 27(4):614-23. PubMed ID: 15941609
[TBL] [Abstract][Full Text] [Related]
12. Promotion of cellular migration and apoptosis resistance by a mouse eye-specific phosphatidylethanolamine-binding protein.
Zhang Y; Wang X; Xiang Z; Li H; Qiu J; Sun Q; Wan T; Li N; Cao X; Wang J
Int J Mol Med; 2007 Jan; 19(1):55-63. PubMed ID: 17143548
[TBL] [Abstract][Full Text] [Related]
13. Role of nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways in IL-1 beta-mediated induction of alpha-PDGF receptor expression in rat pulmonary myofibroblasts.
Lindroos PM; Rice AB; Wang YZ; Bonner JC
J Immunol; 1998 Oct; 161(7):3464-8. PubMed ID: 9759865
[TBL] [Abstract][Full Text] [Related]
14. Understanding perspectives of signalling mechanisms regulating PEBP1 function.
Rajkumar K; Nichita A; Anoor PK; Raju S; Singh SS; Burgula S
Cell Biochem Funct; 2016 Aug; 34(6):394-403. PubMed ID: 27385268
[TBL] [Abstract][Full Text] [Related]
15. Histamine H1 receptor antagonist blocks histamine-induced proinflammatory cytokine production through inhibition of Ca2+-dependent protein kinase C, Raf/MEK/ERK and IKK/I kappa B/NF-kappa B signal cascades.
Matsubara M; Tamura T; Ohmori K; Hasegawa K
Biochem Pharmacol; 2005 Feb; 69(3):433-49. PubMed ID: 15652235
[TBL] [Abstract][Full Text] [Related]
16. Transcript expression bias of phosphatidylethanolamine binding protein gene in bumblebee, Bombus lantschouensis (Hymenoptera: Apidae).
Dong J; Han L; Wang Y; Huang J; Wu J
Gene; 2017 Sep; 627():290-297. PubMed ID: 28647560
[TBL] [Abstract][Full Text] [Related]
17. Raf kinase inhibitor protein (RKIP) in cancer.
Escara-Wilke J; Yeung K; Keller ET
Cancer Metastasis Rev; 2012 Dec; 31(3-4):615-20. PubMed ID: 22684368
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
Kim SO; Kim MR
Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
[TBL] [Abstract][Full Text] [Related]
19. RKIP: much more than Raf kinase inhibitory protein.
Al-Mulla F; Bitar MS; Taqi Z; Yeung KC
J Cell Physiol; 2013 Aug; 228(8):1688-702. PubMed ID: 23359513
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction.
Baritaki S; Chapman A; Yeung K; Spandidos DA; Palladino M; Bonavida B
Oncogene; 2009 Oct; 28(40):3573-85. PubMed ID: 19633685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
